A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma.
Conclusions: HART represents an attractive approach for patients with HNSCC where treatment intensification is indicated.
PMID: 31519130 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Saksø M, Andersen E, Bentzen J, Andersen M, Johansen J, Primdahl H, Overgaard J, Eriksen JG Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | Head and Neck Cancer | History of Medicine | HNSCC | Hypopharyngeal Cancer | Intensity-Modulated Radiation Therapy | Laryngeal Cancer | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Pharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Xerostomia